Table 4 Post-bronchoscopy adverse events and clinical outcomes
| Â | Total population | Propensity score-matched population | ||||
|---|---|---|---|---|---|---|
High oxygen saturation group (n = 458) | Low oxygen saturation group (n = 111) | P-value | High oxygen saturation group (n = 222) | Low oxygen saturation group (n = 111) | P-value | |
Number of patients with post-bronchoscopy adverse events, n (%) | ||||||
 Respiratory events | 43 (9.4) | 23 (20.7) | 0.001 | 24 (10.8) | 23 (20.7) | 0.023 |
 Febrile events | 48 (10.5) | 29 (26.1) |  < 0.001 | 24 (10.8) | 29 (26.1) | 0.001 |
 Hemodynamic events | 33 (7.2) | 7 (6.3) | 0.900 | 16 (7.2) | 7 (6.3) | 0.939 |
 Cardiac events | 11 (2.4) | 6 (5.4) | 0.175 | 10 (4.5) | 6 (5.4) | 0.928 |
 Cerebrovascular events | 0 (0.0) | 1 (0.9) | 0.441 | 0 (0.0) | 1 (0.9) | 0.723 |
 Any adverse events | 103 (22.3) | 35 (32.4) | 0.021 | 49 (22.1) | 38 (34.2) | 0.025 |
Clinical outcomes | Â | Â | Â | Â | Â | Â |
 Hospital length of stay after bronchoscopy, median (IQR) | 2 (1–12) | 4 (1–10) | 0.99 | 1 (1–14) | 2 (1–11) | 0.744 |
 ICU admission after bronchoscopy, n (%) | 18 (3.9) | 9 (8.1) | 0.159 | 8 (3.6) | 9 (8.1) | 0.135 |
 7-day all-cause mortality, n (%) | 5 (1.1) | 3 (2.7) | 0.399 | 5 (2.3) | 3 (2.7) | 1.000 |